Literature DB >> 27226907

Screening for Anti-Cancer Compounds in Marine Organisms in Oman.

Sergey Dobretsov1, Yahya Tamimi2, Mohamed A Al-Kindi3, Ikram Burney4.   

Abstract

OBJECTIVES: Marine organisms are a rich source of bioactive molecules with potential applications in medicine, biotechnology and industry; however, few bioactive compounds have been isolated from organisms inhabiting the Arabian Gulf and the Gulf of Oman. This study aimed to isolate and screen the anti-cancer activity of compounds and extracts from 40 natural products of marine organisms collected from the Gulf of Oman.
METHODS: This study was carried out between January 2012 and December 2014 at the Sultan Qaboos University, Muscat, Oman. Fungi, bacteria, sponges, algae, soft corals, tunicates, bryozoans, mangrove tree samples and sea cucumbers were collected from seawater at Marina Bandar Al-Rowdha and Bandar Al-Khayran in Oman. Bacteria and fungi were isolated using a marine broth and organisms were extracted with methanol and ethyl acetate. Compounds were identified from spectroscopic data. The anti-cancer activity of the compounds and extracts was tested in a Michigan Cancer Foundation (MCF)-7 cell line breast adenocarcinoma model.
RESULTS: Eight pure compounds and 32 extracts were investigated. Of these, 22.5% showed strong or medium anti-cancer activity, with malformin A, kuanoniamine D, hymenialdisine and gallic acid showing the greatest activity, as well as the soft coral Sarcophyton sp. extract. Treatment of MCF-7 cells at different concentrations of Sarcophyton sp. extracts indicated the induction of concentration-dependent cell death. Ultrastructural analysis highlighted the presence of nuclear fragmentation, membrane protrusion, blebbing and chromatic segregation at the nuclear membrane, which are typical characteristics of cell death by apoptosis induction.
CONCLUSION: Some Omani marine organisms showed high anti-cancer potential. The efficacy, specificity and molecular mechanisms of anti-cancer compounds from Omani marine organisms on various cancer models should be investigated in future in vitro and in vivo studies.

Entities:  

Keywords:  Anticancer Agents; Apoptosis; Biological Products; Breast Cancer; Cancer Screening; Marine Organisms; Oman

Year:  2016        PMID: 27226907      PMCID: PMC4868515          DOI: 10.18295/squmj.2016.16.02.006

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  25 in total

Review 1.  Drugs from the seas - current status and microbiological implications.

Authors:  P Proksch; R A Edrada; R Ebel
Journal:  Appl Microbiol Biotechnol       Date:  2002-06-12       Impact factor: 4.813

2.  Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.

Authors:  V Smith; F Raynaud; P Workman; L R Kelland
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

Review 3.  Marine natural products as anticancer drugs.

Authors:  T Luke Simmons; Eric Andrianasolo; Kerry McPhail; Patricia Flatt; William H Gerwick
Journal:  Mol Cancer Ther       Date:  2005-02       Impact factor: 6.261

4.  Developing a new resource for drug discovery: marine actinomycete bacteria.

Authors:  William Fenical; Paul R Jensen
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040

Review 5.  Chemical defenses: from compounds to communities.

Authors:  Valerie J Paul; Karen E Arthur; Raphael Ritson-Williams; Cliff Ross; Koty Sharp
Journal:  Biol Bull       Date:  2007-12       Impact factor: 1.818

Review 6.  Medicinal importance of gallic acid and its ester derivatives: a patent review.

Authors:  Sneha Choubey; Lesley Rachel Varughese; Vinod Kumar; Vikas Beniwal
Journal:  Pharm Pat Anal       Date:  2015

Review 7.  Development of novel drugs from marine surface associated microorganisms.

Authors:  Anahit Penesyan; Staffan Kjelleberg; Suhelen Egan
Journal:  Mar Drugs       Date:  2010-03-01       Impact factor: 5.118

8.  Anticancer drugs from marine flora: an overview.

Authors:  N Sithranga Boopathy; K Kathiresan
Journal:  J Oncol       Date:  2011-02-27       Impact factor: 4.375

9.  In vitro and in silico studies on the anticancer and apoptosis-inducing activities of the sterols identified from the soft coral, subergorgia reticulata.

Authors:  Kuniyil Byju; Vattoni Anuradha; Gopalakrishnapai Vasundhara; S Muraleedharan Nair; N Chandramohana Kumar
Journal:  Pharmacogn Mag       Date:  2014-01       Impact factor: 1.085

Review 10.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.

Authors:  Wamtinga Richard Sawadogo; Marc Schumacher; Marie-Hélène Teiten; Claudia Cerella; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411

View more
  7 in total

1.  A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Authors:  Annelise Carvalho; Jennifer Chu; Céline Meinguet; Robert Kiss; Guy Vandenbussche; Bernard Masereel; Johan Wouters; Alexander Kornienko; Jerry Pelletier; Véronique Mathieu
Journal:  Eur J Pharmacol       Date:  2017-03-18       Impact factor: 4.432

Review 2.  The Phylum Bryozoa as a Promising Source of Anticancer Drugs.

Authors:  Blanca Figuerola; Conxita Avila
Journal:  Mar Drugs       Date:  2019-08-17       Impact factor: 5.118

3.  Marine Invertebrate Extracts Induce Colon Cancer Cell Death via ROS-Mediated DNA Oxidative Damage and Mitochondrial Impairment.

Authors:  Verónica Ruiz-Torres; Celia Rodríguez-Pérez; María Herranz-López; Beatriz Martín-García; Ana-María Gómez-Caravaca; David Arráez-Román; Antonio Segura-Carretero; Enrique Barrajón-Catalán; Vicente Micol
Journal:  Biomolecules       Date:  2019-11-23

Review 4.  Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy.

Authors:  Rama Rao Malla; Batoul Farran; Ganji Purnachandra Nagaraju
Journal:  World J Biol Chem       Date:  2021-03-27

5.  10Z‑Hymenialdisine inhibits angiogenesis by suppressing NF‑κB activation in pancreatic cancer cell lines.

Authors:  Goro Ueda; Yoichi Matsuo; Hiromichi Murase; Yoshinaga Aoyama; Tomokatsu Kato; Kan Omi; Yuichi Hayashi; Hiroyuki Imafuji; Kenta Saito; Ken Tsuboi; Mamoru Morimoto; Ryo Ogawa; Hiroki Takahashi; Akira Mitsui; Masahiro Kimura; Shuji Takiguchi
Journal:  Oncol Rep       Date:  2022-01-11       Impact factor: 3.906

6.  Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines.

Authors:  Nada Abdullah; Najwa Al Balushi; Syed I Hasan; Shadia Al Bahlani; Sergey Dobretsov; Yahya Tamimi; Ikram A Burney
Journal:  Sultan Qaboos Univ Med J       Date:  2021-11-25

7.  Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis.

Authors:  Nada Abdullah; Yahya Tamimi; Sergey Dobretsov; Najwa Al Balushi; Jalila Alshekaili; Hamed Al Balushi; Mahmood Al Kindi; Syed Imran Hassan; Shadia Al Bahlani; Benjamin K Tsang; Ikram A Burney
Journal:  Molecules       Date:  2021-06-13       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.